Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery
- PMID: 8292019
- DOI: 10.1006/bbrc.1994.1003
Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery
Abstract
Deendothelializing balloon injury of rat carotid artery results in progressive intimal smooth muscle cell accumulation and luminal stenosis over 14 days after injury. We have found transient rises (approximately 3-fold maximal increases over the uninjured control value) of the kinase activities of both cdc2 and cdk2, key molecules for cell cycle progression, in the injured carotid artery along with the development of intimal proliferation. The topical application of the antisense, but not the sense, cdc2 and cdk2 phosphorothioate oligodeoxynucleotides dissolved in F127 pluronic gel around the freshly injured artery resulted in reductions of the intimal smooth muscle cell accumulation by 47% and 55% respectively, as estimated by an intimal to medial cross-sectional area ratio, with concomitant decreases in cdc2 and cdk2 kinase activities. These results indicate that both cdc2 and cdk2 kinases are involved in intimal smooth muscle cell accumulation after balloon angioplasty and suggest a potential usefulness of the antisense cdc2 and cdk2 oligonucleotide therapy for arterial stenosis.
Similar articles
-
Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty.Circ Res. 1997 Mar;80(3):418-26. Circ Res. 1997. PMID: 9048663
-
Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.J Clin Invest. 1994 Apr;93(4):1458-64. doi: 10.1172/JCI117123. J Clin Invest. 1994. PMID: 8163650 Free PMC article.
-
Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.J Clin Invest. 1997 May 15;99(10):2334-41. doi: 10.1172/JCI119414. J Clin Invest. 1997. PMID: 9153274 Free PMC article.
-
Antisense strategies to inhibit restenosis.Antisense Nucleic Acid Drug Dev. 1999 Oct;9(5):487-92. doi: 10.1089/oli.1.1999.9.487. Antisense Nucleic Acid Drug Dev. 1999. PMID: 10555157 Review.
-
Antisense therapy for angioplasty restenosis. Some critical considerations.Circulation. 1995 Oct 1;92(7):1981-93. doi: 10.1161/01.cir.92.7.1981. Circulation. 1995. PMID: 7671381 Review.
Cited by
-
Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.J Clin Invest. 1996 Jul 15;98(2):443-50. doi: 10.1172/JCI118810. J Clin Invest. 1996. PMID: 8755655 Free PMC article.
-
The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):4051-5. doi: 10.1073/pnas.92.9.4051. Proc Natl Acad Sci U S A. 1995. PMID: 7732029 Free PMC article.
-
The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease.Drugs. 2000 Aug;60(2):239-48. doi: 10.2165/00003495-200060020-00001. Drugs. 2000. PMID: 10983731 Review.
-
Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms.J Cell Biol. 2000 Feb 7;148(3):543-56. doi: 10.1083/jcb.148.3.543. J Cell Biol. 2000. PMID: 10662779 Free PMC article.
-
The mechanisms of coronary restenosis: insights from experimental models.Int J Exp Pathol. 2000 Apr;81(2):63-88. doi: 10.1046/j.1365-2613.2000.00143.x. Int J Exp Pathol. 2000. PMID: 10762439 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous